FDA Clears At-Home HPV Screening Tool - Takeaway - MDSpire
FDA & Government News

FDA Clears At-Home HPV Screening Tool

Self-collection approach aims to expand screening access

Share

  • 1

    FDA approved Onclarity HPV self-collection kit for at-home use.

  • 2

    Improves access to cervical cancer screening.

  • 3

    60% of cervical cancer cases are among unscreened individuals.

  • 4

    The kit allows patients to send samples for lab analysis.

  • 5

    Covered by insurance, Medicaid, and Medicare.

  • 6

    Collaboration with National Cancer Institute for evaluation.

  • 7

    Results sent to healthcare providers for further care decisions.

Original Source(s)

FDA Clears At-Home HPV Screening Tool

  • by Kathryn Wighton

  • April 8, 2026

Related Content

‘4-Minute Rule’ Guides Cesarean Timing

Physiologic mechanisms and team coordination inform management during maternal cardiac arrest

Hidden Pain After Mastectomy?

Chronic postsurgical pain affects many patients but is often underdiagnosed and undertreated.

The Hidden Differences Between Oral Contraceptives

National adverse-event and prescribing data suggest oral contraceptive formulations differ in reported acne, migraine, anxiety, and depression